Even though our report is the first demonstrating that upregulation of FASN increases the expression of GFPT1, other studies have demonstrated the oncogenic role of GFPT1 in cervical cancers, lung cancers and pancreatic cancers [45,54,55]. The gene discussed is FASN; the disease is lung carcinoma.